Research Article
Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis
Table 3
Survival time and potential prognostic factors in patients with mesothelioma and peritoneal carcinomatosis.
| Prognostic factors | Mesothelioma () | Peritoneal carcinomatosis () | value |
| Median survival time (months) | 11 | 7.5 | 0.034 | Sex (M/F) | 16/27 | 33/49 | 0.741 | Age (years) | 60.7 ± 8.5 | 61.6 ± 12.7 | 0.660 | Ascites glucose level (mmol/L) | 4.83 ± 2.05 | 5.74 ± 1.96 | 0.015 | Ascites albumin level (g/L) | 28.02 ± 3.94 | 25.3 ± 7.21 | 0.046 | Ascites LDH level, median (U/L) | 323 | 252 | 0.293 | Ascites monocyte numbers, median (%) | 70 | 70 | 0.800 | Ascites coenocyte numbers, median (%) | 30 | 30 | 0.800 | Ascites coenocyte-to-monocyte ratio | 0.43 | 0.43 | 0.800 | Serum albumin level (g/L) | 34.14 ± 5.16 | 35.18 ± 5.13 | 0.274 | Serum-ascites albumin gradient (g/L) | 6.74 ± 3.32 | 10.06 ± 4.18 | 0.002 | Serum LDH level, median (U/L) | 191 | 248 | 0.046 | Ascites-serum LDH ratio, median | 2.00 | 1.05 | 0.004 | Blood neutrophil-to-lymphocyte ratio, median | 3.35 | 4.00 | 0.034 |
|
|